This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paola Valsania, MD; James H. Warram, MD, ScD; Lawrence I. Rand, MD; Andrzej S. Krolewski, MD, PhD

Arch Ophthalmol. 1993;111(2):202-206.

Abstract
• Almost all patients with type I and many with type II diabetes develop proliferative retinopathy. This entity consists of two components: new blood vessels on the optic disc (NVD), which frequently lead to visual loss, and new blood vessels elsewhere on the retina (NVE), which do not pose such a serious threat to vision. This study examined determinants of neovascularization specifically on the optic disc in eyes with severe nonproliferative retinopathy. The study eyes were under surveillance as the untreated control eyes of participants in the Diabetic Retinopathy Study. During the 5-year follow-up period, NVE developed in almost all of the eyes, whereas the cumulative incidence of NVD in these same eyes was 64% and varied according to several factors. The risk of NVD in a study eye was increased if the contralateral treated eye had NVD rather than NVE or severe nonproliferative retinopathy (odds ratio [OR], 6.1; P<.0001). It was also increased if the study eye had, at the baseline examination, soft exudates and intraretinal microvascular abnormalities (OR, 5.7; P=.002) or soft exudates alone (OR, 4.0; P=.04). Nephropathy and poor glycemic control were each associated with a twofold increase in risk but neither was statistically significant. Eyes of individuals over 40 years of age were protected from the development of NVD (OR, 0.5; P<.05). The findings of this study support the hypothesis that, in patients with diabetes, the development of NVD is determined by different factors than the development of NVE.

Author Affiliations
From the Epidemiology and Genetics (Drs Valsania, Warram, and Krolewski) and Eye Research (Dr Rand) Sections, Research Division of the Joslin Diabetes Center, Boston, Mass; and the Epidemiology Unit, S. Raffaele Hospital, Milan, Italy (Dr Valsania).

Footnotes
Accepted for publication September 9, 1992.

Reprint requests to Epidemiology and Genetics Section, Research Division, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215 (Dr Krolewski).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Age-Specific Prevalence and Causes of Blindness and Visual Impairment in an Older Population: The Rotterdam Study
Klaver et al.
Arch Ophthalmol 1998;116:653-658.
ABSTRACT | FULL TEXT  

Complication-Free Duration and the Risk of Development of Retinopathy in Elderly Diabetic Patients
Cohen et al.
Arch Intern Med 1998;158:641-644.
ABSTRACT | FULL TEXT